David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

We can all be thankful for the remarkable rebound in the stock market, which has helped to rebuild many portfolios during the past 11 months. Stocks may power yet higher if the economy is indeed on the mend, but concerns remain that we’re due… Read More

When a hot new technology shoots out of the gate, investors often get spoiled. They expect demand to keep growing and growing, and have little patience when the industry hits an inevitable speed bump. In recent years, carbon fiber garnered considerable buzz, as the lightweight — yet super-strong — material found its… Read More

In a highly uncertain environment, one thing is clear. The demand for health care will not merely continue… It will dramatically increase in the years to come. Health care has always been a “defensive” industry, as people get sick no matter… Read More

As some of you know, I enjoy a good game of poker. I also had the pleasure of covering the professional tournament circuit for a number of years as a reporter. In that time, I learned valuable lessons about what it takes to stay in the game -- and about being a disciplined investor. Read More

They say success comes at a price. The same thing applies to capital gains. Most investors forgot that lesson in the 1990s, when high-growth “dot-com” stocks were all the rage. Growth at any price was the name of the game, and some investors paid dearly for it. Read More

Managing a large business can prove daunting when the many moving parts fall out of synch. Yet a fresh set of eyes can help to chart a new course, getting all the pieces moving in harmony. That lesson applies for investors in Cardinal Health (NYSE: CAH). New management has begun… Read More

My friend Barbara phoned and invited me to lunch a few weeks ago. When she offered to pay, I knew something was up. Barbara talked about her workout routine, her daughter’s job search, and her upcoming vacation to Panama. After asking me a cursory question or two,… Read More

“There has never been,” President Obama proclaimed this week, “a program of this scale, moved at this speed, that has been enacted as effectively and as transparently as the recovery act.” This is Mr. Obama’s assessment of his $787 billion stimulus package, which marked its first anniversary… Read More